Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism SV Bava, CN Sreekanth, AKT Thulasidasan, NP Anto, VT Cheriyan, ... The international journal of biochemistry & cell biology 43 (3), 331-341, 2011 | 100 | 2011 |
Chaetocin-induced ROS-mediated apoptosis involves ATM–YAP1 axis and JNK-dependent inhibition of glucose metabolism D Dixit, R Ghildiyal, NP Anto, E Sen Cell death & disease 5 (5), e1212-e1212, 2014 | 97 | 2014 |
Guggulsterone sensitizes glioblastoma cells to Sonic hedgehog inhibitor SANT-1 induced apoptosis in a Ras/NFκB dependent manner D Dixit, R Ghildiyal, NP Anto, S Ghosh, V Sharma, E Sen Cancer letters 336 (2), 347-358, 2013 | 43 | 2013 |
Unraveling the hidden role of a uORF-encoded peptide as a kinase inhibitor of PKCs DR Jayaram, S Frost, C Argov, VB Liju, NP Anto, A Muraleedharan, ... Proceedings of the National Academy of Sciences 118 (40), e2018899118, 2021 | 35 | 2021 |
The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment CK Keerthana, TP Rayginia, SC Shifana, NP Anto, K Kalimuthu, N Isakov, ... Frontiers in immunology 14, 1114582, 2023 | 30 | 2023 |
Heteronemin, a marine natural product, sensitizes acute myeloid leukemia cells towards cytarabine chemotherapy by regulating farnesylation of Ras M Saikia, AP Retnakumari, S Anwar, NP Anto, R Mittal, S Shah, KS Pillai, ... Oncotarget 9 (26), 18115, 2018 | 25 | 2018 |
Insights into an immunotherapeutic approach to combat multidrug resistance in hepatocellular carcinoma AR Devan, AR Kumar, B Nair, NP Anto, A Muraleedharan, B Mathew, ... Pharmaceuticals 14 (7), 656, 2021 | 15 | 2021 |
Targeting K-Ras and apoptosis-driven cellular transformation in cancer I Godwin, NP Anto, SV Bava, MS Babu, GG Jinesh Cell Death Discovery 7 (1), 80, 2021 | 14 | 2021 |
Cytotoxicity of 6-acetonyldihydro-chelerythrin, arnottianamide and 6-(2-hydoxypropyl)-dihydrochelerythrine towards human cancer cell lines M Sreelekha, NP Anto, RJ Anto, PM Shafi NISCAIR-CSIR, India, 2014 | 10 | 2014 |
Cucurbitacin B, Purified and Characterized From the Rhizome of Corallocarpus epigaeus Exhibits Anti-Melanoma Potential SUD Aiswarya, G Vikas, NH Haritha, VB Liju, A Shabna, M Swetha, ... Frontiers in Oncology 12, 903832, 2022 | 9 | 2022 |
Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy NH Haritha, A Nawab, V Vijayakurup, NP Anto, VB Liju, VV Alex, ... Frontiers in oncology 11, 656804, 2021 | 8 | 2021 |
6,6′-Dihydroxythiobinupharidine (DTBN) Purified from Nuphar lutea Leaves Is an Inhibitor of Protein Kinase C Catalytic Activity K Waidha, NP Anto, DR Jayaram, A Golan-Goldhirsh, S Rajendran, ... Molecules 26 (9), 2785, 2021 | 7 | 2021 |
Augmented efficacy of uttroside B over sorafenib in a murine model of human hepatocellular carcinoma M Swetha, CK Keerthana, TP Rayginia, LR Nath, NH Haritha, A Shabna, ... Pharmaceuticals 15 (5), 636, 2022 | 5 | 2022 |
Protein kinase C eta is activated in reactive astrocytes of an Alzheimer's disease mouse model: Evidence for its immunoregulatory function in primary astrocytes A Muraleedharan, N Rotem‐Dai, I Strominger, NP Anto, N Isakov, ... Glia 69 (3), 697-714, 2021 | 5 | 2021 |
Cyclophilin A associates with and regulates the activity of ZAP70 in TCR/CD3-stimulated T cells NP Anto, AK Arya, A Muraleedharan, J Shaik, PR Nath, E Livneh, Z Sun, ... Cellular and Molecular Life Sciences 80 (1), 7, 2023 | 4 | 2023 |
Pharmacological attenuation of melanoma by tryptanthrin pertains to the suppression of MITF-M through MEK/ERK signaling axis A Shabna, J Antony, V Vijayakurup, M Saikia, VB Liju, AP Retnakumari, ... Cellular and Molecular Life Sciences 79 (9), 478, 2022 | 3 | 2022 |
Chaetocin-induced ROS-mediated apoptosis involves ATM-YAP1 axis and JNK-dependent inhibition of glucose metabolism. Cell Death Dis. 2014; 5: e1212 D Dixit, R Ghildiyal, NP Anto, E Sen | 3 | 2014 |
Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy (vol 11, 656804, 2021) NH Haritha, A Nawab, V Vijayakurup, NP Anto, VB Liju, VV Alex, ... FRONTIERS IN ONCOLOGY 13, 2023 | 1 | 2023 |
Abstract P42: Beyond the Canonical: uORF-encoded Micro Peptides as Novel Kinase Inhibitors in Cancer Therapy DR Jayaram, S Frost, C Argov, VB Liju, NP Anto, A Muraleedharan, ... Cancer Research 84 (8_Supplement), P42-P42, 2024 | | 2024 |
PD-1 endocytosis unleashes the cytolytic potential of check-point blockade in tumor immunity EB Saad, A Oroya, NP Anto, M Bachais, CE Rudd bioRxiv, 2024.04. 28.591549, 2024 | | 2024 |